Protease inhibitors for the treatment of hepatitis C virus infection
The hepatitis C virus (HCV) has affected an estimate of 80 million individuals worldwide and is a strain of public health. Around 25–30% of patients in Europe and the US infected with HIV are coinfected with HCV. Despite treatment modalities containing a NS3/4A protease it in combination with pegyla...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
German Medical Science GMS Publishing House
2017-11-01
|
| Series: | GMS Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.egms.de/static/en/journals/id/2017-5/id000034.shtml |